Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phyton Biotech
Delta/Vancouver area, British Columbia, Canadaphytonbiotech.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Phyton Biotech is the world’s largest producer of paclitaxel and docetaxel APIs using proprietary plant cell fermentation technology. The company supplies GMP-grade APIs globally for oncology therapeutics, offering a sustainable alternative to traditional extraction from yew trees. Their products are used in approved cancer therapies worldwide.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculePlant-derived active pharmaceutical ingredient
- Industry
- Contract Manufacturing Organization
02
Partnerships
Mylan Laboratories Ltd FDF R&D CentreMultiple global pharma companies as customers for APIs
Beyond the preview
Go deeper on Phyton Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Phyton Biotech.